Can a simple drug make nose jobs safer and less bruised?

NCT ID NCT05774717

Recruiting now Symptom relief Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving tranexamic acid (TXA) before rhinoplasty (nose job) can lessen bleeding during surgery and reduce bruising and swelling afterward. Sixty adults having cosmetic or functional nose surgery will be randomly assigned to receive TXA or a placebo. Researchers will measure blood loss, swelling, and bruising to see if TXA helps recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tranexamic acid (TXA)
What this could lead to: If it works, this could give surgeons a simple way to reduce bleeding, bruising, and swelling in rhinoplasty patients.
What could go wrong: This is a small, early-phase trial with only 60 people. The results may not apply to all nose surgeries, and TXA carries a small risk of blood clots or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE BLOOD LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Postoperative Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE BLOOD LOSS SURGERY

Contacts and locations

Locations

Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.